vs
Side-by-side financial comparison of Krispy Kreme, Inc. (DNUT) and Enhabit, Inc. (EHAB). Click either name above to swap in a different company.
Krispy Kreme, Inc. is the larger business by last-quarter revenue ($392.4M vs $270.4M, roughly 1.5× Enhabit, Inc.). Krispy Kreme, Inc. runs the higher net margin — -7.1% vs -14.3%, a 7.2% gap on every dollar of revenue. On growth, Enhabit, Inc. posted the faster year-over-year revenue change (4.7% vs -2.9%). Krispy Kreme, Inc. produced more free cash flow last quarter ($27.9M vs $3.3M). Over the past eight quarters, Enhabit, Inc.'s revenue compounded faster (1.5% CAGR vs -5.9%).
Krispy Kreme, Inc. is an American multinational doughnut company and coffeehouse chain. Krispy Kreme was founded by Vernon Rudolph (1915–1973), who bought a yeast-raised recipe from a New Orleans chef, rented a building in 1937 in what is now historic Old Salem in Winston-Salem, North Carolina, and began selling to local grocery stores. Steady growth preceded an ambitious expansion as a public company in the period 2000 to 2016, which ultimately proved unprofitable. In 2016, the company retur...
Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business.
DNUT vs EHAB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $392.4M | $270.4M |
| Net Profit | $-27.8M | $-38.7M |
| Gross Margin | — | — |
| Operating Margin | -1.9% | -12.3% |
| Net Margin | -7.1% | -14.3% |
| Revenue YoY | -2.9% | 4.7% |
| Net Profit YoY | -23.8% | 15.9% |
| EPS (diluted) | $-0.18 | $-0.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $392.4M | $270.4M | ||
| Q3 25 | $375.3M | $263.6M | ||
| Q2 25 | $379.8M | $266.1M | ||
| Q1 25 | $375.2M | $259.9M | ||
| Q4 24 | $404.0M | $258.2M | ||
| Q3 24 | $379.9M | $253.6M | ||
| Q2 24 | $438.8M | $260.6M | ||
| Q1 24 | $442.7M | $262.4M |
| Q4 25 | $-27.8M | $-38.7M | ||
| Q3 25 | $-19.4M | $11.1M | ||
| Q2 25 | $-435.3M | $5.2M | ||
| Q1 25 | $-33.3M | $17.8M | ||
| Q4 24 | $-22.4M | $-46.0M | ||
| Q3 24 | $39.6M | $-110.2M | ||
| Q2 24 | $-5.5M | $-200.0K | ||
| Q1 24 | $-8.5M | $200.0K |
| Q4 25 | -1.9% | -12.3% | ||
| Q3 25 | -1.9% | 6.4% | ||
| Q2 25 | -114.4% | 6.3% | ||
| Q1 25 | -5.4% | 6.1% | ||
| Q4 24 | -2.8% | -16.0% | ||
| Q3 24 | -4.2% | -38.6% | ||
| Q2 24 | 1.6% | 4.3% | ||
| Q1 24 | 2.7% | 4.9% |
| Q4 25 | -7.1% | -14.3% | ||
| Q3 25 | -5.2% | 4.2% | ||
| Q2 25 | -114.6% | 2.0% | ||
| Q1 25 | -8.9% | 6.8% | ||
| Q4 24 | -5.6% | -17.8% | ||
| Q3 24 | 10.4% | -43.5% | ||
| Q2 24 | -1.3% | -0.1% | ||
| Q1 24 | -1.9% | 0.1% |
| Q4 25 | $-0.18 | $-0.76 | ||
| Q3 25 | $-0.11 | $0.22 | ||
| Q2 25 | $-2.55 | $0.10 | ||
| Q1 25 | $-0.20 | $0.35 | ||
| Q4 24 | $-0.13 | $-0.92 | ||
| Q3 24 | $0.23 | $-2.20 | ||
| Q2 24 | $-0.03 | $0.00 | ||
| Q1 24 | $-0.05 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $42.4M | $43.6M |
| Total DebtLower is stronger | $911.9M | $426.0M |
| Stockholders' EquityBook value | $650.1M | $534.0M |
| Total Assets | $2.6B | $1.2B |
| Debt / EquityLower = less leverage | 1.40× | 0.80× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $42.4M | $43.6M | ||
| Q3 25 | $30.7M | $56.9M | ||
| Q2 25 | $21.3M | $37.1M | ||
| Q1 25 | $18.7M | $39.5M | ||
| Q4 24 | $29.0M | $28.4M | ||
| Q3 24 | $25.4M | $45.7M | ||
| Q2 24 | $28.6M | $28.5M | ||
| Q1 24 | $33.1M | $36.5M |
| Q4 25 | $911.9M | $426.0M | ||
| Q3 25 | $906.2M | $441.5M | ||
| Q2 25 | $889.4M | $456.9M | ||
| Q1 25 | $935.0M | $467.3M | ||
| Q4 24 | $844.5M | $492.6M | ||
| Q3 24 | $804.6M | $502.9M | ||
| Q2 24 | $895.0M | $512.7M | ||
| Q1 24 | $881.8M | $526.7M |
| Q4 25 | $650.1M | $534.0M | ||
| Q3 25 | $670.3M | $566.8M | ||
| Q2 25 | $693.6M | $552.4M | ||
| Q1 25 | $1.1B | $543.2M | ||
| Q4 24 | $1.1B | $523.5M | ||
| Q3 24 | $1.2B | $566.1M | ||
| Q2 24 | $1.1B | $674.3M | ||
| Q1 24 | $1.2B | $672.3M |
| Q4 25 | $2.6B | $1.2B | ||
| Q3 25 | $2.6B | $1.2B | ||
| Q2 25 | $2.6B | $1.2B | ||
| Q1 25 | $3.1B | $1.2B | ||
| Q4 24 | $3.1B | $1.2B | ||
| Q3 24 | $3.1B | $1.3B | ||
| Q2 24 | $3.2B | $1.4B | ||
| Q1 24 | $3.2B | $1.4B |
| Q4 25 | 1.40× | 0.80× | ||
| Q3 25 | 1.35× | 0.78× | ||
| Q2 25 | 1.28× | 0.83× | ||
| Q1 25 | 0.85× | 0.86× | ||
| Q4 24 | 0.74× | 0.94× | ||
| Q3 24 | 0.68× | 0.89× | ||
| Q2 24 | 0.79× | 0.76× | ||
| Q1 24 | 0.76× | 0.78× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.0M | $4.4M |
| Free Cash FlowOCF − Capex | $27.9M | $3.3M |
| FCF MarginFCF / Revenue | 7.1% | 1.2% |
| Capex IntensityCapex / Revenue | 4.4% | 0.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-64.0M | $65.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.0M | $4.4M | ||
| Q3 25 | $42.3M | $37.8M | ||
| Q2 25 | $-32.5M | $10.6M | ||
| Q1 25 | $-20.8M | $17.9M | ||
| Q4 24 | $27.0M | $-4.1M | ||
| Q3 24 | $3.3M | $28.4M | ||
| Q2 24 | $33.2M | $9.6M | ||
| Q1 24 | $-17.7M | $17.3M |
| Q4 25 | $27.9M | $3.3M | ||
| Q3 25 | $15.5M | $36.2M | ||
| Q2 25 | $-60.8M | $8.7M | ||
| Q1 25 | $-46.7M | $17.6M | ||
| Q4 24 | $-6.9M | $-4.7M | ||
| Q3 24 | $-22.9M | $27.7M | ||
| Q2 24 | $1.6M | $8.9M | ||
| Q1 24 | $-46.8M | $15.5M |
| Q4 25 | 7.1% | 1.2% | ||
| Q3 25 | 4.1% | 13.7% | ||
| Q2 25 | -16.0% | 3.3% | ||
| Q1 25 | -12.5% | 6.8% | ||
| Q4 24 | -1.7% | -1.8% | ||
| Q3 24 | -6.0% | 10.9% | ||
| Q2 24 | 0.4% | 3.4% | ||
| Q1 24 | -10.6% | 5.9% |
| Q4 25 | 4.4% | 0.4% | ||
| Q3 25 | 7.1% | 0.6% | ||
| Q2 25 | 7.4% | 0.7% | ||
| Q1 25 | 6.9% | 0.1% | ||
| Q4 24 | 8.4% | 0.2% | ||
| Q3 24 | 6.9% | 0.3% | ||
| Q2 24 | 7.2% | 0.3% | ||
| Q1 24 | 6.6% | 0.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | 3.41× | ||
| Q2 25 | — | 2.04× | ||
| Q1 25 | — | 1.01× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.08× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 86.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DNUT
Segment breakdown not available.
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
